JP2005516979A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516979A5
JP2005516979A5 JP2003565227A JP2003565227A JP2005516979A5 JP 2005516979 A5 JP2005516979 A5 JP 2005516979A5 JP 2003565227 A JP2003565227 A JP 2003565227A JP 2003565227 A JP2003565227 A JP 2003565227A JP 2005516979 A5 JP2005516979 A5 JP 2005516979A5
Authority
JP
Japan
Prior art keywords
halogen
alkyl
optionally substituted
cyano
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003565227A
Other languages
English (en)
Japanese (ja)
Other versions
JP4069074B2 (ja
JP2005516979A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/005782 external-priority patent/WO2003065789A2/en
Publication of JP2005516979A publication Critical patent/JP2005516979A/ja
Publication of JP2005516979A5 publication Critical patent/JP2005516979A5/ja
Application granted granted Critical
Publication of JP4069074B2 publication Critical patent/JP4069074B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003565227A 2002-02-08 2003-02-04 N−ビフェニルメチルアミノシクロアルカンカルボキサミド誘導体 Expired - Fee Related JP4069074B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35506202P 2002-02-08 2002-02-08
US41077502P 2002-09-12 2002-09-12
PCT/US2003/005782 WO2003065789A2 (en) 2002-02-08 2003-02-04 N-biphenylmethyl aminocycloalkanecarboxamide derivatives

Publications (3)

Publication Number Publication Date
JP2005516979A JP2005516979A (ja) 2005-06-09
JP2005516979A5 true JP2005516979A5 (https=) 2006-03-23
JP4069074B2 JP4069074B2 (ja) 2008-03-26

Family

ID=27737482

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003565227A Expired - Fee Related JP4069074B2 (ja) 2002-02-08 2003-02-04 N−ビフェニルメチルアミノシクロアルカンカルボキサミド誘導体

Country Status (9)

Country Link
US (1) US7091380B2 (https=)
EP (1) EP1476419B1 (https=)
JP (1) JP4069074B2 (https=)
AT (1) ATE316954T1 (https=)
AU (1) AU2003217728B2 (https=)
CA (1) CA2473778A1 (https=)
DE (1) DE60303441T2 (https=)
ES (1) ES2256727T3 (https=)
WO (1) WO2003065789A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259079B (en) 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives
WO2004019868A2 (en) * 2002-08-29 2004-03-11 Merck & Co., Inc. N-biarylmethyl aminocycloalkanecarboxamide derivatives
EP1654232A4 (en) * 2003-08-07 2008-11-12 Merck & Co Inc SULPHONYL SUBSTITUTED N- (BIARYLMETHYL) AMINOCYCLOPROPANCARBOXYLIC ACID AMIDE
ATE423114T1 (de) * 2004-03-02 2009-03-15 Merck & Co Inc Aminocyclopropancarbonsäureamidderivate als bradykininantagonisten
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP2520561B1 (en) 2007-06-08 2016-02-10 MannKind Corporation IRE-1A Inhibitors
AR070750A1 (es) 2007-08-29 2010-05-05 Boehringer Ingelheim Int Compuestos b1-antagonistas, sus sales farmaceuticamente compatibles, medicamentos que contienen dichos compuestos, uso de los mismos para preparar medicamentos y procedimientoo de preparacion de un medicamento
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
JP5629274B2 (ja) 2009-02-26 2014-11-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ブラジキニンb1アンタゴニストとしての化合物
EA019990B1 (ru) * 2009-06-02 2014-07-30 Бёрингер Ингельхайм Интернациональ Гмбх ПРОИЗВОДНЫЕ АМИДОВ 6,7-ДИГИДРО-5H-ИМИДАЗО[1,2-a]ИМИДАЗОЛ-3-КАРБОНОВОЙ КИСЛОТЫ
US8937073B2 (en) * 2010-08-20 2015-01-20 Boehringer Ingelheim International Gmbh Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
US8592426B2 (en) * 2011-01-24 2013-11-26 Hoffmann—La Roche Inc. Aryl-benzocycloalkyl amide derivatives
KR101373705B1 (ko) 2011-08-05 2014-03-14 동국대학교 산학협력단 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
EP2742030B1 (de) * 2011-08-11 2016-07-27 Bayer Intellectual Property GmbH 1,2,4-triazolyl-substituierte ketoenole zum einsatz im pflanzenschutz
TWI854164B (zh) * 2016-02-01 2024-09-01 美商百歐克斯製藥公司 苯并吡唑化合物及其類似物
US12023319B2 (en) 2016-12-23 2024-07-02 Bayer Pharma Aktiengesellschaft Carboxylic acid aromatic amides
CA3047812A1 (en) 2016-12-23 2018-06-28 Bayer Pharma Aktiengesellschaft Tetrazole containing compounds
JOP20190156B1 (ar) 2016-12-23 2023-09-17 Bayer Pharma AG أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1
WO2019090088A1 (en) * 2017-11-02 2019-05-09 Calico Life Sciences Llc Modulators of the integrated stress pathway
TW202545902A (zh) 2018-10-11 2025-12-01 美商嘉來克生命科學有限責任公司 整合應激路徑之前藥調節劑
PL4038052T3 (pl) * 2019-10-02 2024-08-26 Domain Therapeutics Antagoniści receptora ep4 prostaglandyny e2 (pge2)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds
US5208236A (en) * 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use
DK0655461T3 (da) 1993-11-16 2000-10-02 Novartis Ag Cykliske aminosyrederivater med ACE- og NEP-inhiberende aktivitet
WO1997011717A1 (en) 1995-09-27 1997-04-03 Novartis Ag Treatment of chronic progressive renal failure
FR2743562B1 (fr) * 1996-01-11 1998-04-03 Sanofi Sa Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
US6433185B1 (en) * 1996-01-11 2002-08-13 Sanofi-Synthelabo N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
JP4350306B2 (ja) 1998-04-23 2009-10-21 ノバルティス アクチエンゲゼルシャフト エンドセリン変換酵素のチオール型阻害剤
EP1080104B1 (en) 1998-04-23 2005-02-09 Novartis AG Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme
US20020052370A1 (en) 2000-07-06 2002-05-02 Barber Christopher Gordon Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
DE10036121A1 (de) * 2000-07-25 2002-02-07 Merck Patent Gmbh N-Substituierte-1-amino-1,1-dialkyl-carbonsäurederivate
TWI259079B (en) * 2002-02-08 2006-08-01 Merck & Co Inc N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives

Similar Documents

Publication Publication Date Title
JP2005516979A5 (https=)
JP2005517006A5 (https=)
JP2005537323A5 (https=)
JP2016525075A5 (https=)
NO20070032L (no) Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes
HRP20230789T1 (hr) Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6
JP2014507464A5 (https=)
JP2007517010A5 (https=)
JP2018525375A5 (https=)
JP2007519735A5 (https=)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
JP2014525420A5 (https=)
JP2020516671A5 (https=)
JP2007512349A5 (https=)
JP2012528166A5 (https=)
JP2009533410A5 (https=)
RU2019130519A (ru) 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав
JP2017511357A5 (https=)
RU2005108667A (ru) Производные n-биарилметиламиноциклоалканкарбоксамида
JP2004521095A5 (https=)
JP2018519323A5 (https=)
JP2009534386A5 (https=)
CA2634676A1 (en) Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein cetp
JP2007517044A5 (https=)
RU2019132155A (ru) Ингибиторные соединения